More than one-fourth of new HIV infections in the United States are among persons aged 13 to 24 years, and most of them aren't even aware.
Upadacitinib effective in treating atopic dermatitis through 76 weeks
In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).
Food Insecurity and the Dangers of Infant Formula Dilution
A preview of the November/December issue of Contemporary Pediatrics
Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the final Contemporary Pediatrics journal of the year.
Demystifying Infant Formula
Survey: titrating trofinetide improves tolerability among Rett syndrome patients
Respondents reported decreased diarrhea severity, improved patient quality of life, and decreased treatment discontinuation among patients with Rett syndrome treated with trofinetide.
Weekly review: COVID-19 roundtable, upadacitinib data for AD, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.